Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FIRST ANDAs FILED LEAD TO 63% OF FIRST GENERIC APPROVALS, FDA FIVE-YEAR STUDY FINDS; AVERAGE ANDA TOOK 14.5 MONTHS AND 3.3 REVIEW CYCLES TO APPROVAL
Oct 08 1990
•
By
The Pink Sheet
More from Archive
More from Pink Sheet